Wysocki H, Rybakowski J, Wierusz-Wysocka B, Szajnerman Z, Michta G, Kapelski Z
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(4):533-8.
In 10 psychiatric patients marrow granulocyte reserve, marginal granulocyte pool, granulocyte mobilization into skin chamber, serum lysozyme activity was estimated before and ten days after the lithium treatment. In all patients the peripheral neutrophil count rose significantly. The marrow granulocyte reserve did not change markedly. Moreover, the marginal granulocyte pool as expressed in percentages diminished. Serum lysozyme activity, total leukocyte mobilization, and blood granulocyte clearance remained unchanged. However, the serum lysozyme activity index fell significantly. The in vitro addition of lithium to the suspension of granulocytes obtained from healthy persons reduce the granulocyte adherence especially in concentrations similar to those induced in treated patients. Our findings suggest that lithium in vivo may diminish the granulocyte adherence resulting in the prolonged intravascular half-life time of the cells. Thus, the cell accumulation in the vascular bed seems to be the main reason for lithium induced granulocytosis rather than the intensification of marrow granulocyte system proliferation.
对10名精神科患者在锂治疗前及治疗10天后评估了骨髓粒细胞储备、边缘粒细胞池、粒细胞向皮肤腔室的动员以及血清溶菌酶活性。所有患者外周中性粒细胞计数显著上升。骨髓粒细胞储备无明显变化。此外,以百分比表示的边缘粒细胞池减少。血清溶菌酶活性、总白细胞动员及血液粒细胞清除率保持不变。然而,血清溶菌酶活性指数显著下降。在从健康人获取的粒细胞悬液中体外添加锂会降低粒细胞黏附,尤其是在与治疗患者体内诱导浓度相似的浓度下。我们的研究结果表明,体内锂可能会减少粒细胞黏附,从而导致细胞在血管内的半衰期延长。因此,血管床中的细胞积聚似乎是锂诱导粒细胞增多症的主要原因,而非骨髓粒细胞系统增殖加剧。